Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > The end game??
View:
Post by 99newbie on Jun 04, 2013 10:05am

The end game??

Before rattling on, great to read Dusty's opinions.

My presumption is that you are the "Dusty" of WSCM.

Observations

1. GW wants VMC + AH. Reason: Tax credits (perhaps our biggest hidden asset) & Scalability. They've been there, done that.

2. The value of Onocidin + Immunocidin + tax credits justifies 1.5 X sales alone. And yet, don't expect a penny more for all of AH.

3. Our CEO seems  to value Urocidin the most. Following all the $$$$ spent on R & D, this seems to be the horse he's chosen to ride.

4. Some how Urocidin will be isolated  from the fray. Perhaps our CEO would be quite happy to run this enterprise from a plant in Montreal which he controls( trusting my memory on this one).

Key rule of capital markets- Investors pay more for dreams than Book, Sales or P/E. Rolling over BNC shares for new Urocidin venture makes sense- probably tax-efficient also. The artist formerly called "Urocidin" emerges as a newly exchange listed firm. This is the vehicle that could add to a large shareholder's net wealth far beyond 34 cents/ share.

5. Don't be shocked if Endo returns as partner in Urocidin. What have they really lost? Still have a 5% net interest plus a history of buying all JV partners as I recall.

6. Lastly, there seemingly is lots of $$$$ on the table. This leads me to my conclusion:

We'll never see the majority of value unlocked as Dusty opines- the hidden wealth will accrue to those investors taking our company private.

80 cents it is!

 

99newbie

Comment by Nohandledzep on Jun 04, 2013 10:23am
You may be on to something...Kids just aren't reading the newspaper anymore, the average age onf the unionized plant worker is 59, we can't find any new managers to move this far North and the pulp plant needs a major overhaul.   80 cents it is.
Comment by HighteawithIntrepid on Jun 04, 2013 10:51am
Not tax credits alone of 58 m, we also have NCLCF as noted in the Annual report see pg 85. FYI: If were trading at .10 on the dollar because of the risk of a fire sale FMV is over $3. The last share offering was at 1.40. IMHO: If your pushing .80 you must be working for GW. or related to DimSum. HT
Comment by Verta on Jun 04, 2013 10:53am
Anybody else feel like we are being set up? Like low balling at 80 cents to get us to get excited about a buck?
Comment by 99newbie on Jun 04, 2013 11:04am
Not working for anybody but my greedy self. Good point re NCLCF. I'm wondering about how an acquirer can use these and if residency in Canada must be maintainedestablished. Just can't help thinking that deeper pockets are likely to make far more than I off of BNC. 99newbie
Comment by beechguy on Jun 04, 2013 11:09am
Nice post Newbie. Although you hardly sound like a newbie. You do make a good point about the tax credits. I forgot that in my calculations. We have a 130mm deficit. For a company with significant revenue is a huge bonus if buying Animal health.   I am not sure what the breakdown is for the deficit though. I would imagine when the plant is included the Animal portion would ...more  
Comment by DryBones on Jun 04, 2013 11:33am
This post has been removed in accordance with Community Policy
Comment by HighteawithIntrepid on Jun 04, 2013 12:26pm
Sorry DB, not everyones speaks accountant eh, have a read of the hard copy of the annual report, page 85 Non Capital Loss Carry Forward It states that because of our financial health no value has been put on these amounts. If we sell animal health we could use up these amounts to make it a pretty much tax free transaction. So at 4 times 30M that is $120 net plus, if it were me a royalty ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities